Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Mediwound Ltd Ord Sh (MDWD)

Mediwound Ltd Ord Sh (MDWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 149,589
  • Shares Outstanding, K 9,492
  • Annual Sales, $ 18,690 K
  • Annual Income, $ -6,720 K
  • 60-Month Beta 0.93
  • Price/Sales 8.01
  • Price/Cash Flow N/A
  • Price/Book 4.95
Trade MDWD with:

Options Overview Details

View History
  • Implied Volatility 85.35% ( +5.08%)
  • Historical Volatility 65.49%
  • IV Percentile 97%
  • IV Rank 67.96%
  • IV High 124.92% on 03/20/24
  • IV Low 1.39% on 09/07/23
  • Put/Call Vol Ratio 0.50
  • Today's Volume 9
  • Volume Avg (30-Day) 36
  • Put/Call OI Ratio 0.59
  • Today's Open Interest 969
  • Open Int (30-Day) 748

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.40
  • Number of Estimates 4
  • High Estimate -0.35
  • Low Estimate -0.44
  • Prior Year -0.44
  • Growth Rate Est. (year over year) +9.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.57 +20.97%
on 04/02/24
18.75 -12.48%
on 04/17/24
+0.44 (+2.76%)
since 03/22/24
3-Month
11.04 +48.64%
on 02/06/24
18.75 -12.48%
on 04/17/24
+3.36 (+25.75%)
since 01/23/24
52-Week
7.10 +131.13%
on 09/08/23
18.75 -12.48%
on 04/17/24
+4.47 (+37.44%)
since 04/21/23

Most Recent Stories

More News
MediWound: Q4 Earnings Snapshot

MediWound: Q4 Earnings Snapshot

MDWD : 16.41 (+4.12%)
MediWound: Q3 Earnings Snapshot

MediWound: Q3 Earnings Snapshot

MDWD : 16.41 (+4.12%)
MediWound: Q2 Earnings Snapshot

MediWound: Q2 Earnings Snapshot

MDWD : 16.41 (+4.12%)
MediWound: Q1 Earnings Snapshot

MediWound: Q1 Earnings Snapshot

MDWD : 16.41 (+4.12%)
MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates

MediWound (MDWD) delivered earnings and revenue surprises of -521.05% and 56.79%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

MDWD : 16.41 (+4.12%)
CASI : 2.51 (+3.29%)
MediWound: Q4 Earnings Snapshot

MediWound: Q4 Earnings Snapshot

MDWD : 16.41 (+4.12%)
MediWound (MDWD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

MediWound (MDWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MDWD : 16.41 (+4.12%)
CPRX : 14.73 (-2.45%)
MediWound (MDWD) Reports Q3 Loss, Tops Revenue Estimates

MediWound (MDWD) delivered earnings and revenue surprises of -30% and 24.93%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

MDWD : 16.41 (+4.12%)
CSBR : 5.07 (+0.20%)
CASI Pharmaceuticals, Inc. (CASI) Reports Q3 Loss, Lags Revenue Estimates

CASI Pharmaceuticals, Inc. (CASI) delivered earnings and revenue surprises of 25.49% and 1.80%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...

CASI : 2.51 (+3.29%)
MDWD : 16.41 (+4.12%)
VYNE Therapeutics Inc. (VYNE) Reports Q3 Loss, Tops Revenue Estimates

VYNE Therapeutics Inc. (VYNE) delivered earnings and revenue surprises of 0% and 67%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

VYNE : 2.32 (-1.28%)
MDWD : 16.41 (+4.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

MediWound Ltd. is a biotechnology niche specialty company. It is focused on developing, manufacturing and commercializing products that address unmet needs in the fields of severe burn and chronic wound management. The company is also developing NexoBrid for the removal of eschar, a dead or damaged tissue...

See More

Key Turning Points

3rd Resistance Point 18.09
2nd Resistance Point 17.53
1st Resistance Point 16.97
Last Price 16.41
1st Support Level 15.85
2nd Support Level 15.29
3rd Support Level 14.73

See More

52-Week High 18.75
Last Price 16.41
Fibonacci 61.8% 14.30
Fibonacci 50% 12.93
Fibonacci 38.2% 11.55
52-Week Low 7.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar